Leonardo DRS Inc (DRS)

NASDAQIndustrialsAerospace & DefenseSnapshot 2026-10-23

$34.51+0.61%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Leonardo DRS Inc’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

+0.7%

+10% or more+5%0%−5%−10% or less

1.46 → 1.47 EPS · FY ending Dec 31, 2027 · 7 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 7 to 7; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q4
Revenue	—	1.16B
EPS	—	0.434
FY 2026 · Annual
Revenue	$3.9B–$3.98B	3.95B
EPS	$1.34–$1.39non-GAAP	1.39
EBITDA	$525M–$540Mnon-GAAP	—
FY 2027 · Annual
Revenue	—	4.24B
EPS	—	1.472

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Improve cash from operating activities toward positive	A primary condition in Leonardo DRS Inc's published investment case. The stated target is > 0 USD millions.	Under Pressure	cash from operating activities remains negative or worsens over next 4 quarters	Cash from operations: $35M FY2026-Q2; GAAP. Published target: > 0 USD millions. Target period is not explicitly aligned with this observation. Source published Jul 30, 202635,000,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 2 of last 2 quarters. Operating cash flow improved from a negative $66 million in 2026-Q1 to positive $35 million in 2026-Q2, reflecting better profitability and working capital management. This shows delivering progress on improving cash flow. Delivery assessment Oct 24, 2026
Maintain dividend per share at $0.09	Dividend per share remains steady at $0.09, showing stable capital return.	Intact	dividend per share falls below $0.09	Dividend per share: $0.09 per share FY2026-Q2; GAAP. Published target: >= $0.09 per share. Target period is not explicitly aligned with this observation. Source published Jul 30, 20260.09 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 5f568107-7fa1-4bfd-b559-e52f80647e0f. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 3 of last 3 quarters. Dividend per share has been consistently maintained at $0.09 from 2025-Q4 through 2026-Q2. Management has reiterated this dividend level each quarter, demonstrating consistent capital return to shareholders. Delivery assessment Oct 24, 2026
Earnings per share at least $1.3 in 2026	Earnings per share are expected to grow to $1.3 this year and $1.44 next year.	Intact	EPS falls below $1.3 in 2026	Diluted EPS: $0.32 per share FY2026-Q2; GAAP. Published target: >= $1.3 per share. Target period is not explicitly aligned with this observation. Source published Jul 30, 20260.32 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 5f568107-7fa1-4bfd-b559-e52f80647e0f. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated in 3 of last 3 quarters. Dividend per share has been consistently maintained at $0.09 from 2025-Q4 through 2026-Q2. Management has reiterated this dividend level each quarter, demonstrating consistent capital return to shareholders. Delivery assessment Oct 24, 2026
Revenue reaches at least $3.9 billion in 2026	A primary condition in Leonardo DRS Inc's published investment case. The stated target is >= $3.9 billion.	Intact	annual revenue falls below $3.9 billion in 2026	Revenue: $913M FY2026-Q2; GAAP. Published target: >= $3.9 billion. Target period is not explicitly aligned with this observation. Source published Jul 30, 2026913,000,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 5f568107-7fa1-4bfd-b559-e52f80647e0f. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$1.47

$1.44 → $1.47 · observed estimates

FY2027 revenue$4.24B

$4.20B → $4.24B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$1.44	$4,200,051,784	6 / 7
2026-07-25	$1.44	$4,201,951,130	9 / 9
2026-07-26	$1.44	$4,200,051,784	6 / 7
2026-07-27	$1.44	$4,201,951,130	9 / 9
2026-07-28	$1.44	$4,201,951,130	9 / 9
2026-07-29	$1.44	$4,200,063,034	6 / 7
2026-07-30	$1.44	$4,200,063,034	6 / 7
2026-07-31	$1.44	$4,205,194,152	6 / 7
2026-08-01	$1.44	$4,205,194,152	6 / 7
2026-08-02	$1.45	$4,207,662,360	9 / 9
2026-08-03	$1.47	$4,211,256,410	9 / 9
2026-08-04	$1.47	$4,211,256,410	9 / 9
2026-08-05	$1.47	$4,212,894,190	9 / 9
2026-08-06	$1.46	$4,211,228,166	6 / 7
2026-08-07	$1.46	$4,211,228,166	6 / 7
2026-08-08	$1.47	$4,216,060,860	9 / 9
2026-08-09	$1.47	$4,216,060,860	9 / 9
2026-08-10	$1.46	$4,211,228,166	6 / 7
2026-08-11	$1.47	$4,216,060,860	9 / 9
2026-08-12	$1.47	$4,216,060,860	9 / 9
2026-08-13	$1.47	$4,216,060,860	9 / 9
2026-08-14	$1.46	$4,211,228,166	6 / 7
2026-08-15	$1.46	$4,211,228,166	6 / 7
2026-08-16	$1.46	$4,211,228,166	6 / 7
2026-08-17	$1.46	$4,211,228,166	6 / 7
2026-08-18	$1.46	$4,211,228,166	6 / 7
2026-08-19	$1.46	$4,211,228,166	6 / 7
2026-08-20	$1.46	$4,215,200,686	6 / 7
2026-08-21	$1.46	$4,215,200,686	6 / 7
2026-08-22	$1.46	$4,215,200,686	6 / 7
2026-08-23	$1.46	$4,215,200,686	6 / 7
2026-08-24	$1.46	$4,215,200,686	6 / 7
2026-08-25	$1.46	$4,215,200,686	6 / 7
2026-08-26	$1.46	$4,215,200,686	6 / 7
2026-08-27	$1.46	$4,215,200,686	6 / 7
2026-08-28	$1.46	$4,215,200,686	6 / 7
2026-08-29	$1.46	$4,215,200,686	6 / 7
2026-08-30	$1.46	$4,215,200,686	6 / 7
2026-08-31	$1.46	$4,215,200,686	6 / 7
2026-09-01	$1.46	$4,215,200,686	6 / 7
2026-09-02	$1.46	$4,215,200,686	6 / 7
2026-09-03	$1.46	$4,215,200,686	6 / 7
2026-09-04	$1.46	$4,215,200,686	6 / 7
2026-09-05	$1.46	$4,215,200,686	6 / 7
2026-09-06	$1.46	$4,215,200,686	6 / 7
2026-09-07	$1.46	$4,215,200,686	6 / 7
2026-09-08	$1.46	$4,215,200,686	6 / 7
2026-09-09	$1.46	$4,215,200,686	6 / 7
2026-09-10	$1.46	$4,215,200,686	6 / 7
2026-09-11	$1.46	$4,215,200,686	6 / 7
2026-09-12	$1.46	$4,215,200,686	6 / 7
2026-09-13	$1.46	$4,215,200,686	6 / 7
2026-09-14	$1.46	$4,215,200,686	6 / 7
2026-09-15	$1.46	$4,215,200,686	6 / 7
2026-09-16	$1.46	$4,224,911,721	6 / 7
2026-09-17	$1.46	$4,224,911,721	7 / 7
2026-09-18	$1.46	$4,224,911,721	7 / 7
2026-09-19	$1.46	$4,224,911,721	7 / 7
2026-09-20	$1.46	$4,224,911,655	7 / 7
2026-09-21	$1.46	$4,224,911,655	7 / 7
2026-09-22	$1.46	$4,224,911,655	7 / 7
2026-09-23	$1.46	$4,224,911,655	7 / 7
2026-09-24	$1.46	$4,224,911,655	7 / 7
2026-09-25	$1.46	$4,224,911,655	7 / 7
2026-09-26	$1.46	$4,224,911,655	7 / 7
2026-09-27	$1.46	$4,224,911,655	7 / 7
2026-09-28	$1.46	$4,224,911,655	7 / 7
2026-09-29	$1.46	$4,224,911,655	7 / 7
2026-09-30	$1.46	$4,224,911,655	7 / 7
2026-10-01	$1.46	$4,224,911,655	7 / 7
2026-10-02	$1.46	$4,224,911,655	7 / 7
2026-10-03	$1.46	$4,224,911,655	7 / 7
2026-10-04	$1.46	$4,224,911,655	7 / 7
2026-10-05	$1.46	$4,224,911,655	7 / 7
2026-10-06	$1.46	$4,224,911,655	7 / 7
2026-10-07	$1.46	$4,224,911,655	7 / 7
2026-10-08	$1.46	$4,224,911,655	7 / 7
2026-10-09	$1.46	$4,224,911,655	7 / 7
2026-10-10	$1.47	$4,227,133,877	7 / 7
2026-10-11	$1.47	$4,227,133,877	7 / 7
2026-10-12	$1.47	$4,227,133,877	7 / 7
2026-10-13	$1.47	$4,227,133,877	7 / 7
2026-10-14	$1.47	$4,227,133,877	7 / 7
2026-10-15	$1.47	$4,227,133,877	7 / 7
2026-10-16	$1.47	$4,227,133,877	7 / 7
2026-10-17	$1.47	$4,227,133,877	7 / 7
2026-10-18	$1.47	$4,226,689,289	7 / 7
2026-10-19	$1.47	$4,226,689,289	7 / 7
2026-10-20	$1.47	$4,226,689,289	7 / 7
2026-10-21	$1.47	$4,226,689,289	7 / 7
2026-10-22	$1.47	$4,226,689,289	7 / 7
2026-10-23	$1.47	$4,226,689,289	7 / 7
2026-10-24	$1.47	$4,236,135,717	7 / 8

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	8	2
2026-06-01	8	2
2026-07-01	8	2
2026-08-01	8	2
2026-09-01	9	2
2026-10-01	10	2

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 10 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades1 maintains

Recent actions · Sep 25–Oct 24 · 1 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

OppenheimerOct 22

$45.00New observation · no comparable prior

Morgan StanleyOct 16

$44.00New observation · no comparable prior

$0$24.75$49.50

0 raises · 0 cuts · 0 unchanged · 2 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Improve cash from operating activities toward positivePublished status: Under Pressure
Maintain dividend per share at $0.09Dividend per share: $0.09 per share
Earnings per share at least $1.3 in 2026Diluted EPS: $0.32 per share
Revenue reaches at least $3.9 billion in 2026Revenue: $913M

Next proof point

Oct 29, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.1%Typical daily move · historical

Downside history

-31.7%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Leonardo DRS Inc outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This investment represents a stable growth opportunity within the industrials sector. The current thesis is intact, supported by management's efforts to increase guidance and strategic acquisitions, although there are notable risks from sector performance.

What's priced into Leonardo DRS Inc

The market appears to price DRS as expensive compared to peers, reflecting a justified valuation given its recent performance. However, there is a slight expectations gap, indicating that some future growth may already be anticipated.

What the fundamentals likely do

Management has shown a mixed track record in execution quality, with recent financial performance being neutral. The near-term risk of missing earnings is low, but there is a history of significant misses that could affect future results.

What Leonardo DRS Inc hinges on

The thesis hinges on the performance of sector bellwethers like SPCX, GE, and RTX. If these companies continue to perform well, it could support DRS's growth. Conversely, any negative guidance from these firms could pose a risk to DRS's outlook.